D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 75 Citations 20,046 182 World Ranking 14540 National Ranking 7486

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Internal medicine

Antony Rosen spends much of his time researching Cell biology, Immunology, Biochemistry, Apoptosis and Autoantibody. The concepts of his Cell biology study are interwoven with issues in Biological pathway and Caspase, Programmed cell death. His Caspase research includes themes of Proteases, Granzyme B and Proteolysis.

Immunology is closely attributed to Myositis in his work. His biological study spans a wide range of topics, including Receptor, Lipid raft, Cytoplasm and Colocalization. As a part of the same scientific family, Antony Rosen mostly works in the field of Autoantibody, focusing on Antigen and, on occasion, Mutated citrullinated vimentin, Internal medicine, Rheumatoid arthritis and Rheumatology.

His most cited work include:

  • Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. (1525 citations)
  • Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. (585 citations)
  • Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity (445 citations)

What are the main themes of his work throughout his whole career to date?

Immunology, Autoantibody, Antibody, Autoimmunity and Apoptosis are his primary areas of study. In most of his Immunology studies, his work intersects topics such as Disease. His Autoantibody study incorporates themes from Myositis, Scleroderma, Pathology, Internal medicine and Dermatomyositis.

As part of one scientific family, Antony Rosen deals mainly with the area of Autoimmunity, narrowing it down to issues related to the Epitope, and often Antigen processing. His Apoptosis study integrates concerns from other disciplines, such as Proteases, Poly ADP ribose polymerase, Proteolysis and Cell biology. In his study, Lymphocyte is strongly linked to Cytotoxic T cell, which falls under the umbrella field of Cell biology.

He most often published in these fields:

  • Immunology (45.00%)
  • Autoantibody (35.56%)
  • Antibody (20.56%)

What were the highlights of his more recent work (between 2013-2021)?

  • Immunology (45.00%)
  • Autoantibody (35.56%)
  • Antibody (20.56%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Immunology, Autoantibody, Antibody, Scleroderma and Internal medicine. His Immunology research incorporates elements of Dermatomyositis and Disease. His Autoantibody research is multidisciplinary, relying on both Odds ratio, Immunohistochemistry, Disease pathogenesis, Systemic lupus erythematosus and Breast cancer.

His Epitope study in the realm of Antibody connects with subjects such as In patient. The Internal medicine study which covers Gastroenterology that intersects with Confidence interval and Interquartile range. His studies deal with areas such as Cancer research, Antigen and Cell biology as well as Immune system.

Between 2013 and 2021, his most popular works were:

  • Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer (259 citations)
  • Aggregatibacter actinomycetemcomitans–induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis (228 citations)
  • Molecular Subsetting of Interferon Pathways in Sjögren's Syndrome. (73 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Internal medicine

His primary scientific interests are in Immunology, Autoimmunity, Autoantibody, Antibody and Scleroderma. His work on Immune system, Epitope and Autoimmune disease as part of general Immunology study is frequently linked to Citrullination, therefore connecting diverse disciplines of science. His Autoimmunity study also includes

  • Connective tissue disease which connect with Inclusion body myositis and Polymyositis,
  • Rheumatoid factor, which have a strong connection to Periodontitis.

His work in Autoantibody addresses subjects such as Internal medicine, which are connected to disciplines such as Gastroenterology. His Antibody study combines topics from a wide range of disciplines, such as Interferon, Pathogenesis and Interstitial lung disease. While the research belongs to areas of Scleroderma, Antony Rosen spends his time largely on the problem of Cancer, intersecting his research to questions surrounding RNA polymerase III and Lung cancer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes.

L A Casciola-Rosen;G Anhalt;A Rosen.
Journal of Experimental Medicine (1994)

2012 Citations

Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death.

Livia Casciola-Rosen;Donald W. Nicholson;Tae Chong;Kevin R. Rowan.
Journal of Experimental Medicine (1996)

783 Citations

Autoantibodies against 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase in patients with statin‐associated autoimmune myopathy

Andrew L Mammen;Tae Chung;Lisa Christopher-Stine;Paul Rosen.
Arthritis & Rheumatism (2011)

637 Citations

Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity

Livia Casciola-Rosen;Felipe Andrade;Danielle Ulanet;Wes Bang Wong.
Journal of Experimental Medicine (1999)

614 Citations

Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus.

Livia Casciola-Rosen;Antony Rosen;Michelle Petri;Mark Schlissel.
Proceedings of the National Academy of Sciences of the United States of America (1996)

567 Citations

The Caspase-3 Precursor Has a Cytosolic and Mitochondrial Distribution: Implications for Apoptotic Signaling

Marie Mancini;Donald W. Nicholson;Sophie Roy;Nancy A. Thornberry.
Journal of Cell Biology (1998)

559 Citations

DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis.

Livia A. Casciola-Rosen;Grant J. Anhalt;Antony Rosen.
Journal of Experimental Medicine (1995)

554 Citations

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset.

Raphaela Goldbach-Mansky;Jennifer Lee;Angela McCoy;Joseph Hoxworth.
Arthritis Research (2000)

543 Citations

Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death.

Livia A. Casciola-Rosen;Douglas K. Miller;Grant J. Anhalt;Antony Rosen.
Journal of Biological Chemistry (1994)

541 Citations

Caspase-2 Is Localized at the Golgi Complex and Cleaves Golgin-160 during Apoptosis

Marie Mancini;Carolyn E. Machamer;Sophie Roy;Donald W. Nicholson.
Journal of Cell Biology (2000)

487 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Antony Rosen

Martin Herrmann

Martin Herrmann

University of Erlangen-Nuremberg

Publications: 73

M. Eric Gershwin

M. Eric Gershwin

University of California, Davis

Publications: 72

Joseph A. Trapani

Joseph A. Trapani

Peter MacCallum Cancer Centre

Publications: 62

Ingrid E. Lundberg

Ingrid E. Lundberg

Karolinska University Hospital

Publications: 46

Carlo Selmi

Carlo Selmi

Humanitas University

Publications: 43

David S. Pisetsky

David S. Pisetsky

Duke University

Publications: 39

Neil McHugh

Neil McHugh

University of Bath

Publications: 38

William H. Robinson

William H. Robinson

Stanford University

Publications: 38

Livia Casciola-Rosen

Livia Casciola-Rosen

Johns Hopkins University School of Medicine

Publications: 36

Victoria P. Werth

Victoria P. Werth

University of Pennsylvania

Publications: 35

Jill P. Buyon

Jill P. Buyon

New York University

Publications: 35

Boris Zhivotovsky

Boris Zhivotovsky

Karolinska Institute

Publications: 35

Paul J. Utz

Paul J. Utz

Stanford University

Publications: 35

Gerald W. Hart

Gerald W. Hart

University of Georgia

Publications: 34

Marvin J. Fritzler

Marvin J. Fritzler

University of Calgary

Publications: 34

Angelo A. Manfredi

Angelo A. Manfredi

Vita-Salute San Raffaele University

Publications: 34

Trending Scientists

Stefano Previdi

Stefano Previdi

Huawei Technologies (Italy)

Robert O. Banker

Robert O. Banker

Cisco Systems (United States)

Anita J. Hill

Anita J. Hill

Commonwealth Scientific and Industrial Research Organisation

Paolo Gasparini

Paolo Gasparini

University of Trieste

Christoph Plutzar

Christoph Plutzar

University of Natural Resources and Life Sciences

Finn Kjellberg

Finn Kjellberg

University of Montpellier

Jonathan B. Shurin

Jonathan B. Shurin

University of California, San Diego

Olen M. Kew

Olen M. Kew

Centers for Disease Control and Prevention

Marco Bohnhoff

Marco Bohnhoff

Freie Universität Berlin

Hiroshi Koizumi

Hiroshi Koizumi

Waseda University

Masanobu Shimada

Masanobu Shimada

Tokyo Denki University

Andrew Hyland

Andrew Hyland

Roswell Park Cancer Institute

Hidenori Arai

Hidenori Arai

Kyoto University

Bill Vicenzino

Bill Vicenzino

University of Queensland

Thomas Gehrmann

Thomas Gehrmann

University of Zurich

Sang-Wook Cheong

Sang-Wook Cheong

Rutgers, The State University of New Jersey

Something went wrong. Please try again later.